Anticoagulation options for intermittent haemodialysis
Clicks: 148
ID: 267402
2006
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.3
/100
1 views
1 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Anticoagulation of the extracorporeal circuit, once a major technical problem that delayed the development of chronic intermittent haemodialysis, is today largely taken for granted as part of normal routine practice. The initiation of coagulation in the extracorporeal hemodialysis circuit is a manif ā¦Reference Key |
a2006minervaanticoagulation
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Davenport A;; |
Journal | Minerva urologica e nefrologica = The Italian journal of urology and nephrology |
Year | 2006 |
DOI | DOI not found |
URL | |
Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
thrombosis / etiology*
pmid:16767070
a davenport
anticoagulants / therapeutic use*
heparin / therapeutic use
renal dialysis / adverse effects*
renal dialysis / methods*
thrombosis / prevention & control*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.